How Dr. Mark McKenna Plans To Disrupt The Aesthetics Industry

As a medical doctor and entrepreneur, Dr. Mark McKenna has found quite a bit of success over the years. Once he graduated from Tulane University Medical School he started to practice in his father’s office on patients. He also opened McKenna Venture Investments which bought property all over New Orleans, Lousiana. His real estate investment company was very successful and he even acquired two other local companies in the industry, Universal Mortgage Lending and Uptown Title, Inc.

McKenna Venture Investments employed more than 50 people and offered a variety of services such as closing and financing. However, in 2005 Hurricane Katrina wiped out large segments of New Orleans. Dr. Mark McKenna’s real estate empire ended up literally underwater. He tried to recover for a few years by flipping houses (buy a house, fix it up, and resell for a profit) but since so many people didn’t move back to New Orleans he found this pretty tough. Eventually he moved to Atlanta, Georgia so he could continue his medical career there.

Once in Atlanta, Dr. Mark McKenna launched a new company, ShapeMed. This company specialized in wellness and aesthetics. It was a rather successful company and when he was approached by Life Time Fitness Inc. about acquiring his company he decided to sell it. For a while he worked for this company as their National Medical Director but after this company was itself acquired he decided to once again strike out on his own.

It was in July 2017 that Dr. Mark McKenna launched a new business, OVME. This is a medical aesthetic company with a revolutionary concept. First, it will be national in scope while his competitors all compete only on the local level. Secondly, the procedures won’t be performed in OVME offices. Instead, people will use an app to have a licensed, independent doctor arrive at their house to carry out the procedure. Right now Dr. Mark McKenna is building up this network of medical professionals. He expects to start having the first patients treated in March 2018.

Leave a Reply